[1]李 闯,叶劲松,刘 昕,等.ZBP-89与缺氧信号因子HIF-1α在肝癌细胞中的 相关性研究[J].医学信息,2019,32(15):74-76.[doi:10.3969/j.issn.1006-1959.2019.15.023]
　LI Chuang,YE Jin-song,LIU Xin,et al.Correlation between ZBP-89 and Hypoxia Signaling Factor HIF-1α in Hepatoma Cells[J].Journal of Medical Information,2019,32(15):74-76.[doi:10.3969/j.issn.1006-1959.2019.15.023]
点击复制

ZBP-89与缺氧信号因子HIF-1α在肝癌细胞中的 相关性研究()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年15期
页码:
74-76
栏目:
论著
出版日期:
2019-08-01

文章信息/Info

Title:
Correlation between ZBP-89 and Hypoxia Signaling Factor HIF-1α in Hepatoma Cells
文章编号:
1006-1959（2019）15-0074-03
作者:
李 闯; 叶劲松; 刘 昕; 陈小红; 刘利平; 程书榜
广东省深圳市龙华区人民医院胃肠外科，广东 深圳 518000
Author(s):
LI Chuang; YE Jin-song; LIU Xin; CHEN Xiao-hong; LIU Li-ping; CHENG Shu-bang
Department of Gastrointestinal Surgery,People's Hospital of Longhua District,Shenzhen 518000,Guangdong,China
关键词:
肝癌; ZBP-89; HIF-1α; 缺氧调控因子
Keywords:
Key words：Liver cancer; ZBP-89; HIF-1α; Hypoxia regulator
分类号:
R735.7
DOI:
10.3969/j.issn.1006-1959.2019.15.023
文献标志码:
A
摘要:
目的 探讨ZBP-89在肝癌组织中的表达与缺氧诱导因子HIF-1α的相关性,为证实ZBP-89通过抑制HIF-1α/Notch1信号通路降低肝癌干细胞“干性”提供依据。方法 选择2016年8月~2018年8月深圳市龙华区人民医院与深圳市人民医院肝胆胰外科120例原发性肝癌患者作为研究对象，收集病理标本，采用免疫组化染色方法来检测肝癌细胞及癌旁组织中ZBP-89、HIF-1α的相关表达，分析二者之间的相关性。结果 ZBP-89在肝癌组织中呈现出低表达状态，而在癌旁组织中却呈现出高表达状态，分别为34.17%、62.50%；ZBP-89在癌旁组织中表达高于肝癌组织（P＜0.05）。而在肝癌组织细胞中发现ZBP-89的表达与缺氧信号因子HIF-1α的表达呈负相关（P＜0.05）。结论 ZBP-89很可能为肝癌发生、发展过程中一个潜在的抑癌基因,通过抑制HIF-1α/Notch1通路进而抑制肝癌干细胞增殖、增强肝癌干细胞对化疗药物的敏感性，可能是其发挥抑癌效应的重要机制。
Abstract:
Abstract：Objective To investigate the correlation between the expression of ZBP-89 in hepatocarcinoma and the hypoxia-inducible factor HIF-1α, and to provide evidence for ZBP-89 to reduce the "dryness" of liver cancer stem cells by inhibiting HIF-1α/Notch1 signaling pathway.Methods From August 2016 to August 2018, 120 patients with primary liver cancer in the Department of Hepatobiliary Surgery of Shenzhen Longhua District People's Hospital and Shenzhen People's Hospital were selected as subjects. Pathological specimens were collected and immunohistochemical staining was used to detect liver cancer cells. The correlation expressions of ZBP-89 and HIF-1α in adjacent tissues were analyzed, and the correlation between them was analyzed. Results ZBP-89 showed low expression status in liver cancer tissues, but high expression status (41/120, 75/120) in adjacent tissues 34.17%, 62.50%, respectively; ZBP-89 in adjacent tissues the expression was higher than that of liver cancer tissues (P<0.05). The expression of ZBP-89 was negatively correlated with the expression of hypoxia signal factor HIF-1α in hepatocarcinoma cells (P<0.05).Conclusion ZBP-89 is likely to be a potential tumor suppressor gene in the development and progression of hepatocarcinoma. It can inhibit the proliferation of hepatocellular carcinoma stem cells and enhance the sensitivity of liver cancer stem cells to chemotherapeutic drugs by inhibiting HIF-1α/Notch1 pathway. An important mechanism of effect.

参考文献/References:

[1]Su Y,Cheng R,Zhang J,et al.Interferon-α2b gene-modified human bone marrow mesenchymal stem cells inhibit hepatocellular carcinoma by reducing the Notch1 levels[J].Life Sci,2015, 15(143):18-26. [2]Xiao YF,Yong X,Tang B,et al.Notch and Wnt signaling pathway in cancer:Crucial role and potential therapeutic targets[J].Int J Oncol,2016,48(2):437-449. [3]Wang R,Sun Q,Wang P,et al.Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells[J].Oncotarget,2015,7(5):5754-5768. [4]Mu X,Espanol-Suner R,Mederacke I,et al.Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment[J].J Clin Invest,2015,125(10):3891-3903. [5]Yang SL,Liu LP,Niu L,et al．Downregulation and pro-apoptotic effect of hypoxia-inducible factor 1 alpha in hepatocellular carcinoma[J].Oncotarget,2016,7(23):3457l-34581． [6]Cai MY,Imo RZ,Li YH,et al.High-expression of ZBP-89 correlates with distal metastasis and poor prognosis of patients in clear cell renal cell carcinoma[J].Biochem Biophys Res commun,2012,426(4):636-642． [7]Thienpont B,Steinbacher J,Zhao H,et al.Tumour hypoxia causes DNA hypermethylation by reducing TET activity[J].Nature,2016,17,537(7618):63-68. [8]Yu Y,Wang YY,Wang YQ,et al.Antiangiogenic therapy using endostatin increases the number of ALDH+ lung cancer stem cells by generating intratumor hypoxia[J].Sci Rep,2016(6):34239. [9]Chen YL,Chen PM,Lin PY,et al.ABCG2 Overexpression Confers Poor Outcomes in Hepatocellular Carcinoma of Elderly Patients[J].Anticancer Res,2016,36(6):2983-2988. [10]Semenza GL.Hypoxia-inducible factors in physiology and medicine[J].Cell,2012,148(3):399-408.

相似文献/References:

[1]修朋程,李 腾,李雅林,等.泰山山慈菇对小鼠肝癌的治疗作用及相关免疫机制研究[J].医学信息,2018,31(09):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
　XIU Peng-cheng,LI Teng,LI Ya-lin,et al.Study on the Therapeutic Effect and Mechanism of Taishan Mountain Mushroom on Liver Cancer in Mice[J].Journal of Medical Information,2018,31(15):8.[doi:10.3969/j.issn.1006-1959.2018.09.003]
[2]崔康健,杜成友.肝动脉化疗栓塞联合射频消融治疗肝癌的研究进展[J].医学信息,2018,31(09):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
　CUI Kang-jian,DU Cheng-you.Research Progress of Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation for Liver Cancer[J].Journal of Medical Information,2018,31(15):16.[doi:10.3969/j.issn.1006-1959.2018.09.005]
[3]田 明,常伟平.UbcH10在肝癌中的表达及其与预后的关系[J].医学信息,2019,32(12):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
　IAN Ming,CHANG Wei-ping.Expression of UbcH10 in Hepatocellular Carcinoma and Its Relationship with Prognosis[J].Journal of Medical Information,2019,32(15):77.[doi:10.3969/j.issn.1006-1959.2019.12.024]
[4]许 吉.基于知识图谱和专利地图的我国抗肝癌药物研发态势研究[J].医学信息,2018,31(21):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
　XU Ji.Research and Development Situation of Anti-liver Cancer Drugs in China Based on Knowledge Map and Patent Map[J].Journal of Medical Information,2018,31(15):19.[doi:10.3969/j.issn.1006-1959.2018.21.007]
[5]兰福全,李秀云,卢 斌.四种肿瘤标志物对肝癌诊断的临床意义[J].医学信息,2018,31(21):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
　LAN Fu-quan,LI Xiu-yun,LU Bin.The Clinical Significance of Four Tumor Markers in the Diagnosis of Liver Cancer[J].Journal of Medical Information,2018,31(15):164.[doi:10.3969/j.issn.1006-1959.2018.21.048]
[6]赵瑶瑶,高 川,胡佳杰.循环miRNA监测肝细癌的研究[J].医学信息,2019,32(08):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
　ZHAO Yao-yao,GAO Chuan,HU Jia-jie.Research on the Study of Circulating miRNA for Monitoring Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(15):48.[doi:10.3969/j.issn.1006-1959.2019.08.016]
[7]孙 逊.性化护理对肝癌患者CT引导下射频消融术后 负性情绪及生活质量的影响[J].医学信息,2019,32(17):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
　SUN Xun.Effect of Humanized Nursing on Negative Emotion and Quality of Life after CT-guided Radiofrequency Ablation in Patients with Liver Cancer[J].Journal of Medical Information,2019,32(15):187.[doi:10.3969/j.issn.1006-1959.2019.17.065]
[8]徐 蓓,魏霞丽,常艳琴.肝癌患者术后自我饮食管理体验的质性研究[J].医学信息,2019,32(20):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
　XU Bei,WEI Xia-li,CHANG Yan-qin.Qualitative Study of Postoperative Self-Catering Management Experience in Patients with Liver Cancer[J].Journal of Medical Information,2019,32(15):180.[doi:10.3969/j.issn.1006-1959.2019.20.058]
[9]刘申颖,施彦卿,梅鹏飞,等.超声引导下经皮无水乙醇注射联合射频消融治疗中晚期肝癌的效果[J].医学信息,2019,32(22):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]
　LIU Shen-ying,SHI Yan-qing,MEI Peng-fei,et al.Ultrasound-guided Percutaneous Ethanol Injection Combined with Radiofrequency Ablation for Advanced Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(15):87.[doi:10.3969/j.issn.1006-1959.2019.22.026]
[10]任勇军,闵旭立,徐 浩,等.洛铂联合表柔比星化疗栓塞治疗原发性肝细胞癌的疗效[J].医学信息,2019,32(24):43.[doi:10.3969/j.issn.1006-1959.2019.24.014]
　REN Yong-jun,MIN Xu-li,XU Hao,et al.Efficacy of Loplatin Combined with Epirubicin Chemotherapy and Embolization for Primary Hepatocellular Carcinoma[J].Journal of Medical Information,2019,32(15):43.[doi:10.3969/j.issn.1006-1959.2019.24.014]

更新日期/Last Update: 2019-08-01